RSLS insider trading

ReShape Lifesciences Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
211
Last 90 days
0
Buys / sells
55% / 30%
Market cap

RSLS insider activity at a glance

FilingIQ has scored 211 insider transactions for RSLS since Dec 19, 2017. The most recent filing in our index is dated May 31, 2024.

Across the full history, 115 open-market purchases and 64 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RSLS insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest RSLS Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for RSLS?
FilingIQ tracks 211 Form 4 insider transactions for RSLS (ReShape Lifesciences Inc.), covering filings from Dec 19, 2017 onwards. 0 of those were filed in the last 90 days.
Are RSLS insiders net buyers or net sellers?
Across the full Form 4 history for RSLS, 115 transactions (55%) were open-market purchases and 64 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RSLS insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every RSLS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.